Intravenous and Perineural Dexamethasone for Ultrasound-Guided Axillary Blocks
Study Details
Study Description
Brief Summary
Dexamethasone prolong the duration of brachial plexus blocks, but the optimal route, intravenous (IV) or perineural (PN), remains controversial.
This Multi-centric trial compare IV and PN dexamethasone for ultrasound-guided axillary brachial plexus blocks (AXBs). Research hypothesis is that PN modality will outlast its IV counterpart. Since analgesic duration and sensory duration can be influenced by intake of pain medications and surgical trauma to small cutaneous nerves, the investigators will select motor block duration as the main outcome.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Phase 2/Phase 3 |
Detailed Description
After Ethics Committee of the McGill University Health Centre, a total of 150 patients undergoing upper extremity surgery (below the elbow) will be recruited.
All AXBs will be supervised by one of the coauthors and conducted preoperatively in an induction room. This area will have full access to an oxygen source, resuscitative equipment and drugs.
All patients will have fasted for at least eight hours. An IV cannula will be placed prior the block and will be monitored and given oxygen at 2-4 L/min through nasal cannulas.
Light sedation will be provided for patient comfort if needed.Patients will be placed supine with the shoulder abducted and the elbow flexed. The AXB will have a puncture site superior to the axillary artery. After skin disinfection and draping, a skin wheal will be raised with 3 mL of lidocaine 1.5%.
In both groups, 30 mL of lidocaine 1.0%-bupivacaine 0.25% with epinephrine 5 µ/mL will be used. A 22-gauge, 5 cm block will be advanced under direct US vision toward the musculocutaneous nerve. Six mL of LA will be deposited in this location. The needle will then be directed posterior to the artery, at 6 o'clock position and twenty-four mL of LA will be deposited to obtain a spread around the artery.
Patients will be randomized to receive 8 mg of IV or PN dexamethasone. In the IV group, patients will receive 0.8 mL of dexamethasone (10 mg/mL) intravenously and 0.8 mL of normal saline will be added to the injectate through the block needle. In the PN group, patients will receive 0.8 mL of normal saline intravenously and 0.8 mL of dexamethasone (10 mg/mL) will be added to the injectate through the block needle.
A research assistant will prepare the IV and PN injectates. The operator, patient and investigator assessing the block will be blinded to group allocation.
If placement of the needle tip in the desired location is unsuccessful after 15 minutes, the procedure will be stopped and the patient excluded from the study. Brachial plexus blockade will be carried out using an alternative method. If the alternative method fails as well, the patient will be given general anesthesia and intravenous narcotics will be used for postoperative analgesia
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Active Comparator: Intravenous dexamethasone 8 mg patients receiving intravenous 8 mg of dexamethasone in parallel to ultrasound guided axillary nerve block with a standardized local anesthetic solution |
Other: intravenous 8 mg dexamethasone and perineural 0.8 ml of saline solution
|
| Active Comparator: Perineural dexamethasone 8 mg patient receiving perineural 8 mg of dexamethasone in a mixture with a standardized local anesthetic solution for ultrasound guided axillary block |
Other: intravenous 0,8 ml of saline solution and perineural 8 mg of dexamethasone
|
Outcome Measures
Primary Outcome Measures
- Motor block duration [24 hours]
Duration of the motor block (defined as the temporal interval between the end of LA injection through the block needle and the return of movement to the hand and fingers). Patient is contacted at the next day of the surgery and asked about the time when the motor block started to disappear.
Secondary Outcome Measures
- duration of the sensory block [24 hours]
defined as the temporal interval between the end of LA injection through the block needle and the return of sensation to the hand and fingers
- Analgesia duration [24 hours]
defined as the temporal interval between the end of LA injection through the block needle and the appearance of pain at the surgical site
- Onset time [30 minutes]
Time required to reach a minimal score of 14 points of a total of 16. Sensory blockade will be graded according to a 3-point scale using a cold test: 0 = no block, 1 = analgesia (patient can feel touch, not cold), 2 = anesthesia (patient cannot fee touch). The cold test will be applied with light touch to avoid confusion with deep pressure sensation. Motor blockade will also be graded on a 3-point scale: 0 = no block, 1 = paresis, 2 = paralysis (19). Motor blockade of the musculocutaneous, radial, median and ulnar nerves will be evaluated by elbow flexion (musculocutaneous), thumb abduction (radial), thumb opposition (median) and thumb adduction (ulnar).
- Success rate [30-60 minutes]
Ability to proceed with surgery without the need for intravenous narcotics, general anesthesia, rescue blocks or LA infiltration by the surgeon. Just propofol based sedation (25-80 μg/kg/min) will be permitted if necessary, keeping always response to verbal stimulus.
Other Outcome Measures
- Demographic data [30 minutes]
sex, age, weight, height, type of surgery
- Side effects [30-60 minutes]
vascular puncture, hematoma at the site of puncture, toxic effects of LA
- Persistent deficit [7 days]
All patients will be contacted after 7 days by a blinded observer asking about persistent sensory or motor deficit in relation with the blocked nerves.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Below Elbow surgery
-
Age between 18 and 80 years
-
American Society of Anesthesiologists classification 1-3
-
Body mass index between 18 and 35 kg/m2
Exclusion Criteria:
-
Adults who are unable to give their own consent
-
Pre-existing neuropathy (assessed by history and physical examination)
-
Coagulopathy (assessed by history and physical examination and, if deemed clinically necessary, by blood work up i.e. platelets ≤ 100, International Normalized Ratio ≥ 1.4 or partial prothrombin time ≥ 50)
-
Renal failure (assessed by history and physical examination and, if deemed clinically necessary, by blood work up i.e. creatinine ≥ 100)
-
Hepatic failure (assessed by history and physical examination and, if deemed clinically necessary, by blood work up i.e. transaminases ≥ 100)
-
Allergy to local anesthetics (LAs)
-
Pregnancy
-
Prior surgery in the axillary region
-
Chronic pain syndromes requiring opioid intake at home
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Montreal General Hospital, McGill University | Montreal | Quebec | Canada | H3G 1A4 |
| 2 | Ramathibodi Hospital, Mahidol University, | Bangkok | Thailand | 50200 | |
| 3 | Maharaj Nakorn Chiang Mai Hospital | Chiang Mai | Thailand | 10400 |
Sponsors and Collaborators
- Montreal General Hospital
Investigators
- Principal Investigator: De QH Tran, MD, FRCPC, Associate Professor
Study Documents (Full-Text)
None provided.More Information
Publications
- MontrealGH